Pediatric vaccine adjuvants: Components of the modern vaccinologist's toolbox

Pediatric Infectious Disease Journal

Volumn 34, Issue 12, 2015, Pages 1395-1398

  Dowling, David J ^a,b   Levy, Ofer ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM SALT; IMMUNOLOGICAL ADJUVANT; NANOPARTICLE; POLYELECTROLYTE; SAPONIN; TOLL LIKE RECEPTOR 4 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; VACCINE; VIROSOME;

CHILD; DRUG SAFETY; EMULSION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFANT; MEMBRANE VESICLE; NANOPHARMACEUTICS; OUTER MEMBRANE; PRIORITY JOURNAL; REVIEW; VACCINE PRODUCTION; PEDIATRICS;

ADJUVANTS, IMMUNOLOGIC; HUMANS; PEDIATRICS; VACCINES;

EID: 84944345948     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000893     Document Type: Review

References (25)

1. Levy O, Goriely S, Kollmann TR, Immune response to vaccine adjuvants during the first year of life. Vaccine 2013 31 2500 2505
2. Rappuoli R, Mandl CW, Black S, Vaccines for the twenty-first century society. Nat Rev Immunol 2011 11 865 872
3. O'Neill LA, Golenbock D, Bowie AG, The history of Toll-like receptors-redefining innate immunity. Nat Rev Immunol 2013 13 453 460
4. Dowling DJ, Levy O, Ontogeny of early life immunity. Trends Immunol 2014 35 299 310
5. PrabhuDas M, Adkins B, Gans H, Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 2011 12 189 194
6. Levitz SM, Golenbock DT, Beyond empiricism: informing vaccine development through innate immunity research. Cell 2012 148 1284 1292
7. Plotkin SA, Plotkin SL, The development of vaccines: how the past led to the future. Nat Rev Microbiol 2011 9 889 893
8. Brito LA, Malyala P, O'Hagan DT, Vaccine adjuvant formulations: a pharmaceutical perspective. Semin Immunol 2013 25 130 145
9. Swartz MA, Hirosue S, Hubbell JA, Engineering approaches to immunotherapy. Sci Transl Med 2012 4 148rv9
10. Pulendran B, Ahmed R, Immunological mechanisms of vaccination. Nat Immunol 2011 12 509 517
11. Koff WC, Burton DR, Johnson PR, Accelerating next-generation vaccine development for global disease prevention. Science 2013 340 1232910
12. Bachmann MF, Jennings GT, Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010 10 787 796
13. Flach TL, Ng G, Hari A, Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med 2011 17 479 487
14. Marichal T, Ohata K, Bedoret D, DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 2011 17 996 1002
15. Snape MD, Perrett KP, Ford KJ, Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. JAMA 2008 299 173 184
16. Plotkin SA, Orenstein WA, Offit PA, Vaccines Philadelphia, PA: Saunders; 2012 6th Ed
17. Reed SG, Orr MT, Fox CB, Key roles of adjuvants in modern vaccines. Nat Med 2013 19 1597 1608
18. Duthie MS, Windish HP, Fox CB, Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev 2011 239 178 196
19. Rappuoli R, Aderem A, A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 2011 473 463 469
20. Palmer CD, Ninković J, Prokopowicz ZM, The effect of stable macromolecular complexes of ionic polyphosphazene on HIV Gag antigen and on activation of human dendritic cells and presentation to T-cells. Biomaterials 2014 35 8876 8886
21. Azmi F, Ahmad Fuaad AA, Skwarczynski M, Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother 2014 10 778 796
22. Hubbell JA, Thomas SN, Swartz MA, Materials engineering for immunomodulation. Nature 2009 462 449 460
23. Sanders H, Kaaijk P, van den Dobbelsteen GP, Preclinical evaluation of MenB vaccines: prerequisites for clinical development. Expert Rev Vaccines 2013 12 31 42
24. Flower DR, Systematic identification of small molecule adjuvants. Expert Opin Drug Discov 2012 7 807 817
25. Mastelic B, Garçon N, Del Giudice G, Predictive markers of safety and immunogenicity of adjuvanted vaccines. Biologicals 2013 41 458 468